drugset / Trial / NCT01881763

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

NCT01881763

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study aims to compare outcomes of Electroconvulsive Therapy (ECT) using ketamine versus methohexital anesthesia in depressed patients. The investigators hypothesize that patients who receive ketamine anesthesia during ECT will achieve remission status faster than those receiving methohexital anesthesia. Also, at the end of the ECT course subjects will display fewer cognitive side effects compared to those treated with methohexital anesthesia.

Timeline

Start
2010-06
Primary completion
2017-03
Completion
2017-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 1 mg/kg Intravenous
Subject Ketamine Small molecule 2 mg/kg Intravenous
Comparator Methohexital Small molecule 0.5 mg/kg Intravenous
Comparator Methohexital Small molecule 1 mg/kg Intravenous